registrati

Registrati
Hai dimenticato la password?

Cronologia di ricerca
Promemoria
Collegamenti a eurolibro.it
Impostazioni dei cookie

Soffiata di eurolibro.it

Vendi un libro

Strumento di ricerca

Attuale

- 5 Risultati

prezzo più basso: € 117,69, prezzo più alto: € 192,59, prezzo medio: € 160,53

Tumors of the Central Nervous System, Volume 5 : Astrocytomas, Hemangioblastomas, and Gangliogliomas - Vladimir N. Pokrovskii

(*)

Vladimir N. Pokrovskii:
Tumors of the Central Nervous System, Volume 5 : Astrocytomas, Hemangioblastomas, and Gangliogliomas - nuovo libro

ISBN: 9789400720190

The most recent developments in diagnostic and therapeutic aspects of Gliomas (glioblastoma) in the brain are presented. The importance of personalized medicine and clinical validation f… Altro …

The most recent developments in diagnostic and therapeutic aspects of Gliomas (glioblastoma) in the brain are presented. The importance of personalized medicine and clinical validation for targeted therapy are discussed. The identification of various types of biomarkers (determined by molecular genetics) is included, along with their advantages and limitations as markers in tumor detection and diagnosis. The identification and validation of brain cancer (glioblastoma) genes are discussed. The role of cancer stem cells in the initiation and persistence of malignant gliomas is explained; response of glioblastoma cancer stem cells to various growth factors, such as epidermal growth factor receptor kinase inhibitor, is explained. The use of surgical resection, chemotherapy (e.g., temozolomide), immunotherapy, and radiation therapy for glioblastoma patients is included. Biological impediments for chemotherapy and radiotherapy for malignant glioblastoma are pointed out. Standard (established) as well as newer imaging modalities (proton magnetic resonance spectroscopy) are discussed. Also included are proton magnetic resonance spectroscopy in intracranial gliomas, and the use of proton magnetic spectroscopic imaging in determining the infiltration zone in gliomas. The role of molecular signaling in the CNS cancer development is explained, including cell death signaling in glioblastoma multiforme. The most recent developments in diagnostic and therapeutic aspects of Gliomas (glioblastoma) in the brain are presented. The importance of personalized medicine and clinical validation for targeted therapy are discussed. The identification of various types of biomarkers (determined by molecular genetics) is included, along with their advantages and limitations as markers in tumor detection and diagnosis. The identification and validation of brain cancer (glioblastoma) genes are discussed. The role of cancer stem cells in the initiation and persistence of malignant gliomas is explained; response of glioblastoma cancer stem cells to various growth factors, such as epidermal growth factor receptor kinase inhibitor, is explained. The use of surgical resection, chemotherapy (e.g., temozolomide), immunotherapy, and radiation therapy for glioblastoma patients is included. Biological impediments for chemotherapy and radiotherapy for malignant glioblastoma are pointed out. Standard (established) as well as newer imaging modalities (proton magnetic resonance spectroscopy) are discussed. Also included are proton magnetic resonance spectroscopy in intracranial gliomas, and the use of proton magnetic spectroscopic imaging in determining the infiltration zone in gliomas. The role of molecular signaling in the CNS cancer development is explained, including cell death signaling in glioblastoma multiforme.; PDF; Scientific, Technical and Medical > Clinical & internal medicine > Diseases & disorders > Oncology, Springer Netherlands<

hive.co.uk

No. 9789400720190. Costi di spedizione:Instock, Despatched same working day before 3pm, zzgl. Versandkosten., Costi di spedizione aggiuntivi
Details...

(*) Libro esaurito significa che il libro non è attualmente disponibile in una qualsiasi delle piattaforme associate che di ricerca.

Tumors of the Central Nervous System, Volume 5

(*)

Tumors of the Central Nervous System, Volume 5 - nuovo libro

ISBN: 9789400720190

The most recent developments in diagnostic and therapeutic aspects of Gliomas (glioblastoma) in the brain are presented. The importance of personalized medicine and clinical validation f… Altro …

The most recent developments in diagnostic and therapeutic aspects of Gliomas (glioblastoma) in the brain are presented. The importance of personalized medicine and clinical validation for targeted therapy are discussed. The identification of various types of biomarkers (determined by molecular genetics) is included, along with their advantages and limitations as markers in tumor detection and diagnosis. The identification and validation of brain cancer (glioblastoma) genes are discussed. The role of cancer stem cells in the initiation and persistence of malignant gliomas is explained; response of glioblastoma cancer stem cells to various growth factors, such as epidermal growth factor receptor kinase inhibitor, is explained. The use of surgical resection, chemotherapy (e.g., temozolomide), immunotherapy, and radiation therapy for glioblastoma patients is included. Biological impediments for chemotherapy and radiotherapy for malignant glioblastoma are pointed out. Standard (established) as well as newer imaging modalities (proton magnetic resonance spectroscopy) are discussed. Also included are proton magnetic resonance spectroscopy in intracranial gliomas, and the use of proton magnetic spectroscopic imaging in determining the infiltration zone in gliomas. The role of molecular signaling in the CNS cancer development is explained, including cell death signaling in glioblastoma multiforme. The most recent developments in diagnostic and therapeutic aspects of Gliomas (glioblastoma) in the brain are presented. The importance of personalized medicine and clinical validation for targeted therapy are discussed. The identification of various types of biomarkers (determined by molecular genetics) is included, along with their advantages and limitations as markers in tumor detection and diagnosis. The identification and validation of brain cancer (glioblastoma) genes are discussed. The role of cancer stem cells in the initiation and persistence of malignant gliomas is explained; response of glioblastoma cancer stem cells to various growth factors, such as epidermal growth factor receptor kinase inhibitor, is explained. The use of surgical resection, chemotherapy (e.g., temozolomide), immunotherapy, and radiation therapy for glioblastoma patients is included. Biological impediments for chemotherapy and radiotherapy for malignant glioblastoma are pointed out. Standard (established) as well as newer imaging modalities (proton magnetic resonance spectroscopy) are discussed. Also included are proton magnetic resonance spectroscopy in intracranial gliomas, and the use of proton magnetic spectroscopic imaging in determining the infiltration zone in gliomas. The role of molecular signaling in the CNS cancer development is explained, including cell death signaling in glioblastoma multiforme., Springer<

Springer.com

Nr. 978-94-007-2019-0. Costi di spedizione:Worldwide free shipping, , DE. (EUR 0.00)
Details...

(*) Libro esaurito significa che il libro non è attualmente disponibile in una qualsiasi delle piattaforme associate che di ricerca.

Tumors of the Central Nervous System, Volume 5 : Astrocytomas, Hemangioblastomas, and Gangliogliomas - Harn-wei Kua

(*)

Harn-wei Kua:
Tumors of the Central Nervous System, Volume 5 : Astrocytomas, Hemangioblastomas, and Gangliogliomas - nuovo libro

ISBN: 9789400720190

This comprehensive source on the families of tumors of the title is the fifth volume in a series and covers every clinical aspect, from diagnosis (including imaging techniques) to therapy… Altro …

hive.co.uk

No. 9789400720190. Costi di spedizione:Instock, Despatched same working day before 3pm, zzgl. Versandkosten., Costi di spedizione aggiuntivi
Details...

(*) Libro esaurito significa che il libro non è attualmente disponibile in una qualsiasi delle piattaforme associate che di ricerca.

Tumors of the Central Nervous System, Volume 5 - M.A. Hayat

(*)

M.A. Hayat:
Tumors of the Central Nervous System, Volume 5 - nuovo libro

2011, ISBN: 9789400720190

Astrocytomas, Hemangioblastomas, and Gangliogliomas, eBooks, eBook Download (PDF), 2012, [PU: Springer Netherland], Springer Netherland, 2011

lehmanns.de

Costi di spedizione:Download sofort lieferbar. (EUR 0.00)
Details...

(*) Libro esaurito significa che il libro non è attualmente disponibile in una qualsiasi delle piattaforme associate che di ricerca.

Tumors of the Central Nervous System, Volume 5 - M.A. Hayat; M.A. Hayat

(*)

M.A. Hayat; M.A. Hayat:
Tumors of the Central Nervous System, Volume 5 - Prima edizione

2011, ISBN: 9789400720190

Astrocytomas, Hemangioblastomas, and Gangliogliomas, [ED: 1], Auflage, eBook Download (PDF), eBooks, [PU: Springer-Verlag]

lehmanns.de

Costi di spedizione:Download sofort lieferbar, , Versandkostenfrei innerhalb der BRD. (EUR 0.00)
Details...

(*) Libro esaurito significa che il libro non è attualmente disponibile in una qualsiasi delle piattaforme associate che di ricerca.

1

Tumors of the Central Nervous System, Volume 5 : Astrocytomas, Hemangioblastomas, and Gangliogliomas - Vladimir N. Pokrovskii

Ordina
da hive.co.uk

£ 118,58

(indicativi € 140,84)

Dettagli & spedizione

Link sponsorizzato

Vladimir N. Pokrovskii:

Tumors of the Central Nervous System, Volume 5 : Astrocytomas, Hemangioblastomas, and Gangliogliomas - nuovo libro

ISBN: 9789400720190

The most recent developments in diagnostic and therapeutic aspects of Gliomas (glioblastoma) in the brain are presented. The importance of personalized medicine and clinical validation f… Altro …

The most recent developments in diagnostic and therapeutic aspects of Gliomas (glioblastoma) in the brain are presented. The importance of personalized medicine and clinical validation for targeted therapy are discussed. The identification of various types of biomarkers (determined by molecular genetics) is included, along with their advantages and limitations as markers in tumor detection and diagnosis. The identification and validation of brain cancer (glioblastoma) genes are discussed. The role of cancer stem cells in the initiation and persistence of malignant gliomas is explained; response of glioblastoma cancer stem cells to various growth factors, such as epidermal growth factor receptor kinase inhibitor, is explained. The use of surgical resection, chemotherapy (e.g., temozolomide), immunotherapy, and radiation therapy for glioblastoma patients is included. Biological impediments for chemotherapy and radiotherapy for malignant glioblastoma are pointed out. Standard (established) as well as newer imaging modalities (proton magnetic resonance spectroscopy) are discussed. Also included are proton magnetic resonance spectroscopy in intracranial gliomas, and the use of proton magnetic spectroscopic imaging in determining the infiltration zone in gliomas. The role of molecular signaling in the CNS cancer development is explained, including cell death signaling in glioblastoma multiforme. The most recent developments in diagnostic and therapeutic aspects of Gliomas (glioblastoma) in the brain are presented. The importance of personalized medicine and clinical validation for targeted therapy are discussed. The identification of various types of biomarkers (determined by molecular genetics) is included, along with their advantages and limitations as markers in tumor detection and diagnosis. The identification and validation of brain cancer (glioblastoma) genes are discussed. The role of cancer stem cells in the initiation and persistence of malignant gliomas is explained; response of glioblastoma cancer stem cells to various growth factors, such as epidermal growth factor receptor kinase inhibitor, is explained. The use of surgical resection, chemotherapy (e.g., temozolomide), immunotherapy, and radiation therapy for glioblastoma patients is included. Biological impediments for chemotherapy and radiotherapy for malignant glioblastoma are pointed out. Standard (established) as well as newer imaging modalities (proton magnetic resonance spectroscopy) are discussed. Also included are proton magnetic resonance spectroscopy in intracranial gliomas, and the use of proton magnetic spectroscopic imaging in determining the infiltration zone in gliomas. The role of molecular signaling in the CNS cancer development is explained, including cell death signaling in glioblastoma multiforme.; PDF; Scientific, Technical and Medical > Clinical & internal medicine > Diseases & disorders > Oncology, Springer Netherlands<

No. 9789400720190. Costi di spedizione:Instock, Despatched same working day before 3pm, zzgl. Versandkosten., Costi di spedizione aggiuntivi

Info su andamento dei prezzi

2

Tumors of the Central Nervous System, Volume 5

Ordina
da Springer.com

€ 117,69

Spedizione: € 0,00¹

Dettagli del offerente

Link sponsorizzato

Tumors of the Central Nervous System, Volume 5 - nuovo libro

ISBN: 9789400720190

The most recent developments in diagnostic and therapeutic aspects of Gliomas (glioblastoma) in the brain are presented. The importance of personalized medicine and clinical validation f… Altro …

The most recent developments in diagnostic and therapeutic aspects of Gliomas (glioblastoma) in the brain are presented. The importance of personalized medicine and clinical validation for targeted therapy are discussed. The identification of various types of biomarkers (determined by molecular genetics) is included, along with their advantages and limitations as markers in tumor detection and diagnosis. The identification and validation of brain cancer (glioblastoma) genes are discussed. The role of cancer stem cells in the initiation and persistence of malignant gliomas is explained; response of glioblastoma cancer stem cells to various growth factors, such as epidermal growth factor receptor kinase inhibitor, is explained. The use of surgical resection, chemotherapy (e.g., temozolomide), immunotherapy, and radiation therapy for glioblastoma patients is included. Biological impediments for chemotherapy and radiotherapy for malignant glioblastoma are pointed out. Standard (established) as well as newer imaging modalities (proton magnetic resonance spectroscopy) are discussed. Also included are proton magnetic resonance spectroscopy in intracranial gliomas, and the use of proton magnetic spectroscopic imaging in determining the infiltration zone in gliomas. The role of molecular signaling in the CNS cancer development is explained, including cell death signaling in glioblastoma multiforme. The most recent developments in diagnostic and therapeutic aspects of Gliomas (glioblastoma) in the brain are presented. The importance of personalized medicine and clinical validation for targeted therapy are discussed. The identification of various types of biomarkers (determined by molecular genetics) is included, along with their advantages and limitations as markers in tumor detection and diagnosis. The identification and validation of brain cancer (glioblastoma) genes are discussed. The role of cancer stem cells in the initiation and persistence of malignant gliomas is explained; response of glioblastoma cancer stem cells to various growth factors, such as epidermal growth factor receptor kinase inhibitor, is explained. The use of surgical resection, chemotherapy (e.g., temozolomide), immunotherapy, and radiation therapy for glioblastoma patients is included. Biological impediments for chemotherapy and radiotherapy for malignant glioblastoma are pointed out. Standard (established) as well as newer imaging modalities (proton magnetic resonance spectroscopy) are discussed. Also included are proton magnetic resonance spectroscopy in intracranial gliomas, and the use of proton magnetic spectroscopic imaging in determining the infiltration zone in gliomas. The role of molecular signaling in the CNS cancer development is explained, including cell death signaling in glioblastoma multiforme., Springer<

Nr. 978-94-007-2019-0. Costi di spedizione:Worldwide free shipping, , DE. (EUR 0.00)

Info su andamento dei prezzi

3

Tumors of the Central Nervous System, Volume 5 : Astrocytomas, Hemangioblastomas, and Gangliogliomas - Harn-wei Kua

Ordina
da hive.co.uk

£ 141,53

(indicativi € 158,94)

Dettagli & spedizione

Link sponsorizzato

Harn-wei Kua:
Tumors of the Central Nervous System, Volume 5 : Astrocytomas, Hemangioblastomas, and Gangliogliomas - nuovo libro

ISBN: 9789400720190

This comprehensive source on the families of tumors of the title is the fifth volume in a series and covers every clinical aspect, from diagnosis (including imaging techniques) to therapy… Altro …

No. 9789400720190. Costi di spedizione:Instock, Despatched same working day before 3pm, zzgl. Versandkosten., Costi di spedizione aggiuntivi

Info su andamento dei prezzi

4

Tumors of the Central Nervous System, Volume 5 - M.A. Hayat

Ordina
da lehmanns.de

€ 192,59

Spedizione: € 0,00¹

Dettagli del offerente

Link sponsorizzato

M.A. Hayat:
Tumors of the Central Nervous System, Volume 5 - nuovo libro

2011, ISBN: 9789400720190

Astrocytomas, Hemangioblastomas, and Gangliogliomas, eBooks, eBook Download (PDF), 2012, [PU: Springer Netherland], Springer Netherland, 2011

Costi di spedizione:Download sofort lieferbar. (EUR 0.00)

Info su andamento dei prezzi

5

Tumors of the Central Nervous System, Volume 5 - M.A. Hayat; M.A. Hayat

Ordina
da lehmanns.de

€ 192,59

Spedizione: € 0,00¹

Dettagli del offerente

Link sponsorizzato

M.A. Hayat; M.A. Hayat:
Tumors of the Central Nervous System, Volume 5 - Prima edizione

2011, ISBN: 9789400720190

Astrocytomas, Hemangioblastomas, and Gangliogliomas, [ED: 1], Auflage, eBook Download (PDF), eBooks, [PU: Springer-Verlag]

Costi di spedizione:Download sofort lieferbar, , Versandkostenfrei innerhalb der BRD. (EUR 0.00)

Info su andamento dei prezzi

¹Poiché alcune piattaforme non trasmettono le condizioni di spedizione e queste possono dipendere dal paese di consegna, dal prezzo di acquisto, dal peso e dalle dimensioni dell'articolo, dall'eventuale iscrizione alla piattaforma, dalla consegna diretta da parte della piattaforma o tramite un fornitore terzo (Marketplace), ecc. è possibile che le spese di spedizione indicate da eurolibro non corrispondano a quelle della piattaforma offerente.

Dati bibliografici del miglior libro corrispondente

Dettagli del libro

Tumors of the Central Nervous System, Volume 5

Autore:	M.A. Hayat
Titolo:	Tumors of the Central Nervous System, Volume 5
ISBN:	9789400720190

Informazioni dettagliate del libro - Tumors of the Central Nervous System, Volume 5

EAN (ISBN-13): 9789400720190
ISBN (ISBN-10): 940072019X
Anno di pubblicazione: 2011
Editore: Springer Netherland
290 Pagine
Lingua: eng/Englisch

Libro nella banca dati dal 2012-06-09T01:24:14+02:00 (Rome)
Pagina di dettaglio ultima modifica in 2024-03-13T19:46:20+01:00 (Rome)
ISBN/EAN: 9789400720190

ISBN - Stili di scrittura alternativi:
94-007-2019-X, 978-94-007-2019-0
Stili di scrittura alternativi e concetti di ricerca simili:
Autore del libro : hayat
Titolo del libro: tumors the central nervous system

Dati dell'editore

Autore: M.A. Hayat
Titolo: Tumors of the Central Nervous System; Tumors of the Central Nervous System, Volume 5 - Astrocytomas, Hemangioblastomas, and Gangliogliomas
Editore: Springer; Springer Netherland
290 Pagine
Anno di pubblicazione: 2011-09-28
Dordrecht; NL
Stampato / Fatto in
Lingua: Inglese
192,59 € (DE)
198,00 € (AT)
220,50 CHF (CH)
Available
XXVI, 290 p.

EA; E107; eBook; Nonbooks, PBS / Medizin/Nichtklinische Fächer; Onkologie; Verstehen; Biomarkers for cancer; Cancer diagnosis, intraoperative; Cancer therapy; Gene expression in cancer; Imaging of cancer; B; Cancer Research; Neuroradiology; Neurosurgery; Oncology; Surgery; Pathology; Cancer Biology; Neuroradiology; Neurosurgery; Oncology; Surgery; Pathology; Medicine; Medizinische Bildverarbeitung: Radiologie; Neurochirurgie; Chirurgie; Pathologie; BB

Introduction. Part 1. ASTROCYTOMAS. DIAGNOSIS AND BIOMARKERS.-1. Methylation in malignant astrocytomas.-2. Deciphering the function of doppel protein in astrocytomas.-3. Astrocytic tumors: role of antiapoptotic proteins.-4. Astrocytomas: role of wnt/β- catenin/tcf signaling pathway.-5. Subependymal giant cell astrocytoma: role of mtor pathway.-6. Role of progesterone preceptor isoforms in human astrocytomas growth.-7. Astrocytic tumors: role of carbonic anhydrase ix.-8. Development of cysts in pilocytic astrocytomas: role of eosinophilic granular bodies (method).-9. Role of synemin in astrocytoma cell migration.-10. Diffuse astrocytomas: immunohistochemistry of mgmt expression.-11. Central nervous system germ cell tumors: an epidemiology review.-12. Raf genes and mapk activation in pilocytic astrocytomas.-13. Biomarker discovery in central nervous system neoplasms: past, present and future.-14. Astrocytomas: role of taurine in apoptosis using magnetic resonance spectroscopy.-15. Imaging of hypoxia-inducible factor-1-active regions in tumors using a pos and 123i-ibb method.-16. Diffuse low-grade astrocytomas: p53-mediated inhibition of angiogenesis.-17. Spontaneous regression of cerebellar astrocytomas mansoor foroughi, shibu pillai, and paul steenbok.-18. Subependymal giant cell astrocytoma: gene expression profiling magdalena ewa tyburczy and bozena kaminska. THERAPY. -19. Time- resolved laser induced fluorescence spectroscopy (trlifs): a tool for intra-operative diagnosis of brain tumors and maximizing extent of surgical resection.-20. Magnetic resonance-guided laser interstitial thermal therapy for brain tumors.-21. Nanotechnology-based therapy for malignant tumors of the central nervous system.-22. Pilocytic astrocytoma: pthological and immunohistochemical factors affecting surgical treatment and surveillance.-23. Pilomyxoid astrocytoma: chemotherapy hitoshi tsugu, shinya oshiro, fuminari komatsu, hiroshi abe, takeo fukushima, tooru inoue, fumio yanai, yuko nomura. PROGNOSIS. -24. Astrocytomas: predicting survival and recurrence using cerebral blood volume measurements.-25. Electronic patient-reported outcome monitoring (eprom) in brain tumour patients. Part 2. HEMANGIOBLASTOMA.-26. Intra-operative icg use in the management of hemangioblastomas.-27. Hemangioblastoma cysts: diagnosis using fluorescence with 5-aminolevulinic acid.-28. Hemangioblastoma-stereotactic radiosurgery anand veeravagu, bowen jiang, and steven chang. Part 3.GANGLIOGLIOMA.-29. Gangliogliomas: molecular pathogenesis and epileptogenesis eleonora aronica and pitt niehusmann.-30. Epilepsy-associated gangliogliomas: identification of genes with altered expression. Index

Altri libri che potrebbero essere simili a questo:

Ultimo libro simile:
9789400703438 Tumors of the Central Nervous System, Volume 1: Gliomas: Glioblastoma (Part 1) M. A. Hayat Editor (Herausgegeben:Hayat, M. A.; Hayat, M. A.)

Tumors of the Central Nervous System, (Rubinstein, Lucien J.)

Sviluppo dei prezzi...

< Per archiviare...